For those new to PAB and the fight against cancer.
Multiple power full products that are proving to be safe giving them the leading edge.
Significant 10 yr survival benefit for PAT SC-1.
Combination trial to commence shortly or has it already ? with Amgen using PAT SM 6 already proved up and a deal at the end of it. I would have thought after two months into the trial Amgen and Patry's should have enough to go off to sign a deal.
Remember PAB looked as if it was going to go well over 10cents prior to the cash raising, now they have millions in the bank.
Low risk, high reward. Management have poured jaw dropping amounts of their own cash in, my opinion the perfect spec stock although pretty de-risked as far as I can see if anyone can see why not please let me know.
- Forums
- ASX - By Stock
- PAB
- combination trial with agmen
combination trial with agmen
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.258M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $2.652K | 662.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 24059180 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 7489761 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 24059180 | 0.004 |
29 | 26431298 | 0.003 |
16 | 21470001 | 0.002 |
14 | 51291998 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 7489761 | 10 |
0.006 | 9669918 | 11 |
0.007 | 1525381 | 3 |
0.008 | 75000 | 1 |
0.010 | 275230 | 2 |
Last trade - 14.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online